|
Blue Zones, an Analysis of Existing Evidence through a Scoping Review (paper 2026)
|
|
0
|
149
|
May 15, 2026
|
|
Fisetin Attenuates D-Gal-Induced Ovarian Aging by Modulating Mitophagy via the AMPK/mTOR Pathway
|
|
0
|
135
|
May 15, 2026
|
|
Bryan Johnson Longevity Protocol Discussion (2024 / 25 /26)
|
|
420
|
39068
|
May 15, 2026
|
|
Analyses of arts engagement and physical activity in the UK Household Longitudinal Study
|
|
0
|
97
|
May 15, 2026
|
|
The Glycine Blueprint: Rebuilding Mitochondrial Metabolism to Halt Decay
|
|
9
|
674
|
May 15, 2026
|
|
Short-Term Dietary Intervention Alters PhysiologicalProfiles Relevant to Ageing (paper April 2026)
|
|
0
|
169
|
May 15, 2026
|
|
Retinal biological age correlates with bone mineral density and fracture risk score and predicts incident osteoporosis (paper 14 May 26)
|
|
1
|
156
|
May 15, 2026
|
|
Microbiome-Linked Metabolic Architecture of Accelerated Biological Aging in Humans
|
|
0
|
127
|
May 15, 2026
|
|
Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults (paper 1 april 26)
|
|
0
|
140
|
May 15, 2026
|
|
Hazel Szeto, SS-31 peptide, the World's First FDA-Approved Mitochondria-targeted Drug (Longevity Summit, 2025)
|
|
313
|
25930
|
May 15, 2026
|
|
Olive Oil’s "Dark Horse" Metabolite Triggers Autophagy and Reverses Senescence in Human Muscle
|
|
13
|
2644
|
May 14, 2026
|
|
Creatine Supplementation and its Potential Applications for Brain Health and Function
|
|
6
|
2067
|
May 14, 2026
|
|
Continuous glucose monitoring for the masses is here
|
|
29
|
3837
|
May 14, 2026
|
|
Rapamycin Dosing for Longevity: What Emerging Human Research Reveals About How Dose and Timing Shape Autophagy Without Compromising Metabolic Health
|
|
4
|
1035
|
May 14, 2026
|
|
Bench to bedside: is rapamycin headed for the docTOR? - GeroScience (paper 13 May 2026)
|
|
0
|
248
|
May 14, 2026
|
|
How a Croatian Lab Spawned a Buzzy Peptide (BPC-157) Now Popular With MAHA
|
|
30
|
2653
|
May 14, 2026
|
|
The Everything Technology and Longevity Thread
|
|
310
|
23013
|
May 14, 2026
|
|
Everolimus clears 80% of dormant tumour cells (DCT) in patients with confirmed DCT's
|
|
5
|
903
|
May 14, 2026
|
|
Old worms, new tricks: dynamical instability explains late-life rejuvenation in C. elegans (preprint may 26)
|
|
0
|
143
|
May 14, 2026
|
|
Peptides / Bioregulators
|
|
1030
|
72060
|
May 14, 2026
|
|
The Culprit of Aging - Helen Blau's work at Stanford / PGE2, 15-PDGH
|
|
92
|
14148
|
May 14, 2026
|
|
The microplastics thread. Food, Packaging, Utensils, etc
|
|
445
|
33527
|
May 14, 2026
|
|
Bench to bedside: is rapamycin headed for the docTOR?
|
|
2
|
265
|
May 14, 2026
|
|
Optimal Blood Pressure we Should Target? Systolic Under 110 or 100?
|
|
739
|
65840
|
May 14, 2026
|
|
Whole Genome Sequencing
|
|
70
|
6123
|
May 14, 2026
|
|
Bryan Johnson, Is he the New Poster Child for Rapamycin Use?
|
|
703
|
65260
|
May 13, 2026
|
|
The Peptides Quietly Accelerating Aging. Dr Valter Longo interviewed by Simon Hill
|
|
8
|
529
|
May 13, 2026
|
|
The Adiponectin Paradox: Fat’s Secret Longevity Signal or a Bio-Marker of Decline?
|
|
4
|
288
|
May 13, 2026
|
|
Are we wrong about the perfect protein intake?
|
|
167
|
9300
|
May 13, 2026
|
|
Anti-aging Benefits of Rapamycin, Personal Experiences (part 2)
|
|
121
|
38588
|
May 13, 2026
|